American Journal of Kidney Diseases
Volume 52, Issue 2 , Pages 211-215 , August 2008

Grading Evidence-Based Guidelines—What Are the Issues?

  • Katrin Uhlig, MD, MS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Katrin Uhlig, MD, MS, Division of Nephrology, Department of Medicine, Tufts Medical Center, Box 391, 800 Washington St, Boston, MA 02111.
    • ,
  • Ethan M. Balk, MD, MPH
    • ,
  • Joseph Lau, MD

References 

  1. Kidney Disease Improving Global Outcomes (KDIGO) website. http://www.kdigo.orgAccessed June 23, 2008
  2. Uhlig K, Balk EM, Lau J, et al. Clinical practice guidelines in nephrology–for worse or for better. Nephrol Dial Transplant. 2006;21:1145–1153
  3. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490
  4. Uhlig K, Macleod A, Craig J, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology (A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)). Kidney Int. 2006;70:2058–2065
  5. Sawaya GF, Guirguis-Blake J, LeFevre M, et al. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med. 2007;147:871–875
  6. Wolff T, Guirguis-Blake J, Miller T, et al. Screening for carotid artery stenosis: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147:860–870
  7. KDIGO. KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl. 2008;109:S1–S99
  8. Gordon C, Uhlig K, Lau J, et al. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection—a systematic review of the literature and meta-analysis of treatment efficacy and harms. Am J Kidney Dis. 2008;51:263–277
  9. Pagliari C, Grimshaw J, Eccles M. The potential influence of small group processes on guideline development. J Eval Clin Pract. 2001;7:165–173
  10. Djulbegovic B, Frohlich A, Bennett CL. Acting on imperfect evidence: How much regret are we ready to accept?. J Clin Oncol. 2005;23:6822–6825
  11. West S, King V, Carey T, et al. Systems to Rate the Strength of Scientific Evidence (Evidence Report/Technology Assessment No. 47. AHRQ Publication No 02-E016). Rockville, MD: Agency for Healthcare Research and Quality; 2002;April
  12. Schunemann HJ, Best D, Vist G, et al. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ. 2003;169:677–680
  13. King SB, Smith SC, Hirshfeld JW, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation. 2008;117:261–295
  14. Glasziou P, Vandenbroucke JP, Chalmers I. Assessing the quality of research. BMJ. 2004;328:39–41

PII: S0272-6386(08)00994-3

doi: 10.1053/j.ajkd.2008.06.002

American Journal of Kidney Diseases
Volume 52, Issue 2 , Pages 211-215 , August 2008

Article Tools